The safety of APX3330, an oral drug candidate for the treatment of diabetic eye disease, in the ongoing masked 24-week ZETA-1 Phase 2 clinical trial
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE(2022)